TABLE 4.
Various NMOFs as contrast agents for biomedical imaging.
NMOFs | Active ingredient | Contrast media | Biomedical imaging technologies | Refs |
---|---|---|---|---|
Gd(BDC)1.5(H2O)2 | Ga3+ ion | T1-weighted MRI | MRI | Rieter et al. (2006) |
Gd-Ru | Ga3+ ion | T1-weighted MRI | MRI | Wang Y M et al. (2016) |
Mn-NMOF | Mn2+ ion | T1-weighted MRI | MRI | Yang et al. (2016) |
MIL-88A | Fe3+ ion | T2-weighted MRI | MRI | Horcajada et al. (2010) |
MIL-100 | Fe3+ ion | |||
Fe3O4@UiO-66 | Fe3O4 nanoparticle | T2-weighted MRI | MRI | Zhao S N et al. (2016) |
Zr-UiO | Zr3+ ion | - | CT | Kalra et al. (2004) |
Hf-UiO | Hf4+ ion | |||
Au@MIL-88(Fe) | Fe3+ ion | T2-weighted MRI | MRI and CT | Shang et al. (2017) |
Mn/Hf-IR825 | Mn2+ ion | - | MRI and CT | Yang Y et al. (2017) |
89Zr-UiO-66 | Zr3+ ion | - | PET | Chen D et al. (2017) |
UCNP@Fe-MIL-101-NH2 | Fe3+ ion | T2-weighted MRI | Optical imaging and MRI | Li et al. (2015) |
MOF@HA@ICG | indocyanine green (ICG) NIR dye Fe3+ ion | - | Optical imaging and PPT | Cai et al. (2017) |